Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bjophthalmol-2020-317907
PubMed Identifier: 33687999
Publication URI: http://europepmc.org/abstract/MED/33687999
Type: Journal Article/Review
Volume: 106
Parent Publication: The British journal of ophthalmology
Issue: 8
ISSN: 0007-1161